Detailed information for compound 1730398

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 435.559 | Formula: C26H33N3O3
  • H donors: 1 H acceptors: 3 LogP: 3.77 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)n1ncc2c1C(C)(C)CCN(C2=O)[C@@H]1C2CC3CC1C[C@@](C2)(C3)O
  • InChi: 1S/C26H33N3O3/c1-25(2)8-9-28(22-17-10-16-11-18(22)14-26(31,12-16)13-17)24(30)21-15-27-29(23(21)25)19-4-6-20(32-3)7-5-19/h4-7,15-18,22,31H,8-14H2,1-3H3/t16?,17?,18?,22-,26+
  • InChiKey: XIBIIXAMIWORAE-WAXDZURTSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Mus musculus hydroxysteroid 11-beta dehydrogenase 1 Starlite/ChEMBL References
Homo sapiens hydroxysteroid (11-beta) dehydrogenase 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium tuberculosis Probable oxidoreductase Get druggable targets OG5_132866 All targets in OG5_132866
Mycobacterium ulcerans short chain dehydrogenase Get druggable targets OG5_132866 All targets in OG5_132866

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum steroid dehydrogenase, putative hydroxysteroid 11-beta dehydrogenase 1 292 aa 246 aa 25.2 %
Plasmodium falciparum steroid dehydrogenase, putative hydroxysteroid (11-beta) dehydrogenase 1 292 aa 250 aa 24.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) microfilarial chitinase 0.0237 0.0629 0.1641
Echinococcus multilocularis Hepatocellular carcinoma associated antigen 59 0.0387 0.383 0.5
Entamoeba histolytica chitinase, putative 0.0244 0.0768 0.5
Onchocerca volvulus Putative endochitinase 0.0273 0.1396 0.2052
Brugia malayi Endochitinase 0.0273 0.1396 0.2052
Echinococcus granulosus Hepatocellular carcinoma associated antigen 59 0.0387 0.383 0.5
Schistosoma mansoni hypothetical protein 0.0387 0.383 0.5
Brugia malayi endochitinase 0.0273 0.1396 0.2052
Loa Loa (eye worm) hypothetical protein 0.0387 0.383 1
Onchocerca volvulus Putative endochitinase 0.0273 0.1396 0.2052
Loa Loa (eye worm) hypothetical protein 0.0387 0.383 1
Brugia malayi Hepatocellular carcinoma-associated antigen 59 family protein 0.0387 0.383 1
Onchocerca volvulus 0.0387 0.383 1
Onchocerca volvulus 0.0387 0.383 1
Loa Loa (eye worm) cuticular endochitinase 0.0244 0.0768 0.2004
Plasmodium vivax hypothetical protein, conserved 0.0387 0.383 0.5
Leishmania major chitinase 0.0244 0.0768 0.5
Toxoplasma gondii hypothetical protein 0.0387 0.383 0.5
Onchocerca volvulus Putative endochitinase 0.0273 0.1396 0.2052
Loa Loa (eye worm) chitinase I 0.0244 0.0768 0.2004
Plasmodium falciparum conserved protein, unknown function 0.0387 0.383 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 11.1 nM Inhibition of 11beta-HSD1 in human liver microsomes using cortisone and NADPH as substrate by HTRF assay ChEMBL. 23414800
IC50 (binding) > 100 nM Inhibition of mouse 11beta-HSD1 expressed in HEK293 cells using cortisone and NADPH as substrate by HTRF assay ChEMBL. 23414800

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.